Download presentation
Presentation is loading. Please wait.
Published byHoward Atkins Modified over 6 years ago
1
Schematic representation of the pathways of PP-ribose-P and purine nucleotide synthesis and the regulation of rates of purine synthesis de novo by PP-ribose-P and purine nucleotide end products. Curved arrows depict single-step purine base salvage pathways of purine nucleotide synthesis, requiring PP-ribose-P and catalyzed by the phosphoribosyltransferase (PRT) enzymes, HPRT and adenine PRT. Purine synthesis de novo is shown by a solid arrow (representing the rate-limiting AmidoPRT reaction) and a dashed arrow (depicting the final nine steps in this sequence of reactions). Purine nucleotide inhibition (−) of PP-ribose-P synthetase and AmidoPRT is indicated by the heavy hatched arrow, and allosteric activation (+) of AmidoPRT by PP-ribose-P is shown by the heavy dark arrow. (Reprinted with permission from Becker MA, Kim M, Husain K, Kang T: Regulation of purine nucleotide synthesis in human B lymphoblasts with both hypoxanthine-guanine phosphoribosyltransferase deficiency and phosphoribosylpyrophosphate synthetase superactivity. J Biol Chem 267:4317, 1992; reproduced from previous version of OMMBID Hyperuricemia and Gout chapter written by M. Becker.) Source: Hyperuricemia and Gout, The Online Metabolic and Molecular Bases of Inherited Disease Citation: Valle D, Beaudet AL, Vogelstein B, Kinzler KW, Antonarakis SE, Ballabio A, Gibson K, Mitchell G. The Online Metabolic and Molecular Bases of Inherited Disease; 2014 Available at: Accessed: November 09, 2017 Copyright © 2017 McGraw-Hill Education. All rights reserved
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.